CorMedix (CRMD) Profit After Tax (2010 - 2025)

CorMedix has disclosed Profit After Tax across 16 years of filings, most recently posting $108.6 million for Q3 2025.

• Profit After Tax for Q3 2025 came in at $108.6 million, up 4009.63% year-over-year; the trailing twelve-month figure through Dec 2025 was $131.2 million (up 831.93% YoY), and the FY2025 annual result was $1.7 million, up 109.48% from the prior year.
• Profit After Tax came in at $108.6 million for Q3 2025 at CorMedix, up from $2.0 million in the prior quarter.
• In the past five years, Profit After Tax ranged from a high of $108.6 million in Q3 2025 to a low of -$14.8 million in Q4 2023.
• The 5-year median for Profit After Tax is -$7.6 million (2022), against an average of $476653.9.
• Across the five-year window, Profit After Tax plunged 79.77% in 2023 and jumped 4009.63% in 2025, its largest moves.
• CorMedix's Profit After Tax stood at -$7.8 million in 2021, then retreated by 5.34% to -$8.2 million in 2022, then slumped by 79.77% to -$14.8 million in 2023, then surged by 191.26% to $13.5 million in 2024, then jumped by 706.3% to $108.6 million in 2025.
• The last three Profit After Tax figures came in at $108.6 million (Q3 2025), $2.0 million (Q2 2025), and $20.6 million (Q1 2025), per Business Quant data.